Lx Therapies Overview
- Year Founded
-
2008
- Status
-
Private
- Latest Deal Type
-
M&A
Lx Therapies General Information
Description
Provider of gene-mediated therapies. The company operates a drug discovery company which provides gene-mediated therapies for the prevention and treatment of lymphatic vasculature diseases.
Contact Information
Corporate Office
- Tukholmankatu 8 A
- Biomedicum 2a
- 00290 Helsinki
- Finland
Corporate Office
- Tukholmankatu 8 A
- Biomedicum 2a
- 00290 Helsinki
- Finland
Lx Therapies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 25-May-2011 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 14-Jan-2009 | Completed | Startup |
Lx Therapies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Lx Therapies FAQs
-
When was Lx Therapies founded?
Lx Therapies was founded in 2008.
-
Where is Lx Therapies headquartered?
Lx Therapies is headquartered in Helsinki, Finland.
-
What industry is Lx Therapies in?
Lx Therapies’s primary industry is Drug Discovery.
-
Is Lx Therapies a private or public company?
Lx Therapies is a Private company.
-
What is Lx Therapies’s current revenue?
The current revenue for Lx Therapies is .
-
How much funding has Lx Therapies raised over time?
Lx Therapies has raised $2.76M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
